Introduction premature ejaculation (PE) is one of the most common sexual disorders in men.
Objectives Considering the importance of sexual health in men, especially patients with epilepsy, this study was conducted with the aim of comparing premature ejaculation in men with focal epilepsy and generalized tonic-clonic seizure (GTCS).
Methods In this cross-sectional and observational study, patients with epilepsy were included in the study. The examined patients were examined by psychiatrists and neurologists, and sampling was done according to the entry and exit criteria. The total sample size was 200 people, including 100 patients with focal epilepsy and 100 patients with GTCS. The tools used included demographic profile form, Men Sexual Health Questionnaire (MSHQ), Sexual Quality of Life-Men (SQOL-M), and Premature Ejaculation Diagnostic Tool (PEDT). The study was conducted to include patients referred to specialized clinics and hospitals and who had the necessary conditions to participate in the study. Considering that all the patients were male, the questioning was done by a male researcher. Then, the extracted data were entered into SPSS statistical software.
Results Result showed, the M(SD) age of the patients in the focal epilepsy group was equal to 30.18(3.85). M(SD) score of MSHQ tool was equal to 51.81 (11.98), SQOL-M tool was equal to 34.75 (9.36) and PEDT tool was equal to 8.63 (4.79). In this study, although the M(SD) of the PE score in the focal epilepsy group was reported to be 9.17 (4.49) higher than that of the GTCS group with a rate of 8.09 (5.04), but this difference was not significant. also, the findings showed that there was a significant relationship between the status of the PEDT score, the status of the SQOL-M score, and the MSH score (p < 0.05). MSHQ score and SQOL-M score were reported to be lower in patients with PE disorder.
Conclusion According to the findings, the prevalence of sexual disorders including PE in both groups of patients with epilepsy is significant. For this reason, it is necessary to carry out pharmacological and non-pharmacological interventions to reduce the rate of PE in these patients.